126 related articles for article (PubMed ID: 10787358)
1. Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues.
Faquin WC; Fitzgerald JT; Lin MC; Boynton KA; Muto MG; Mutter GL
Am J Clin Pathol; 2000 Apr; 113(4):576-82. PubMed ID: 10787358
[TBL] [Abstract][Full Text] [Related]
2. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability.
Jovanovic AS; Boynton KA; Mutter GL
Cancer Res; 1996 Apr; 56(8):1917-21. PubMed ID: 8620514
[TBL] [Abstract][Full Text] [Related]
3. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
[TBL] [Abstract][Full Text] [Related]
4. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma.
Cao SN; Chang KH; Luthra R; Liu J
Mod Pathol; 2003 Oct; 16(10):1048-52. PubMed ID: 14559989
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.
Chapel DB; Yamada SD; Cowan M; Lastra RR
Gynecol Oncol; 2018 Jun; 149(3):570-574. PubMed ID: 29656794
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite instability (MSI) analysis in patients with endometrial cancer.
Dec G; Romanowicz-Makowska H; Smolarz B; Kulig A
Pol J Pathol; 2005; 56(1):15-9. PubMed ID: 15921009
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma.
Li L; Yue P; Song Q; Yen TT; Asaka S; Wang TL; Beavis AL; Fader AN; Jiao Y; Yuan G; Shih IM; Song Y
J Pathol; 2021 Jan; 253(1):119-128. PubMed ID: 33016334
[TBL] [Abstract][Full Text] [Related]
8. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
[TBL] [Abstract][Full Text] [Related]
9. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
[TBL] [Abstract][Full Text] [Related]
10. Cancerous 'floater': a lesson learned about tissue identity testing, endometrial cancer and microsatellite instability.
Bossuyt V; Buza N; Ngo NT; Much MA; Asis MC; Schwartz PE; Hui P
Mod Pathol; 2013 Sep; 26(9):1264-9. PubMed ID: 23558568
[TBL] [Abstract][Full Text] [Related]
11. Favorable survival associated with microsatellite instability in endometrioid endometrial cancers.
Maxwell GL; Risinger JI; Alvarez AA; Barrett JC; Berchuck A
Obstet Gynecol; 2001 Mar; 97(3):417-22. PubMed ID: 11239648
[TBL] [Abstract][Full Text] [Related]
12. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis.
Mutter GL; Wada H; Faquin WC; Enomoto T
Mol Pathol; 1999 Oct; 52(5):257-62. PubMed ID: 10748874
[TBL] [Abstract][Full Text] [Related]
13. Vanishing endometrial cancer in hysterectomy specimens: a myth or a fact.
Ahmed QF; Gattoc L; Al-Wahab Z; Abdulfatah E; Ruterbusch JJ; Cote M; Bandyopadhyay S; Morris RT; Ali-Fehmi R
Am J Surg Pathol; 2015 Feb; 39(2):221-6. PubMed ID: 25517962
[TBL] [Abstract][Full Text] [Related]
14. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
[TBL] [Abstract][Full Text] [Related]
15. [Amplification and expression of HER-2 oncogene in precancerous stages and cancers of the endometrium].
Czerwenka KF; Heuss F; Zeillinger R; Hosmann JW; Wagner T; Manavi M; Jelincic D; Lu Y; Kubista E
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():287-8. PubMed ID: 7906978
[No Abstract] [Full Text] [Related]
16. Vanishing endometrial carcinoma.
Dubé V; Macdonald D; Allingham-Hawkins DJ; Kamel-Reid S; Colgan TJ
Int J Gynecol Pathol; 2007 Jul; 26(3):271-7. PubMed ID: 17581411
[TBL] [Abstract][Full Text] [Related]
17. Hysterscopic Resection of Premalignant and Malignant Endometrial Polyps: Is it a Safe Alternative to Hysterectomy?
Elyashiv O; Sagiv R; Kerner R; Keidar R; Menczer J; Levy T
J Minim Invasive Gynecol; 2017; 24(7):1200-1203. PubMed ID: 28802955
[TBL] [Abstract][Full Text] [Related]
18. Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.
Mutter GL; Monte NM; Neuberg D; Ferenczy A; Eng C
Cancer Res; 2014 May; 74(10):2796-802. PubMed ID: 24662919
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.
Caduff RF; Johnston CM; Svoboda-Newman SM; Poy EL; Merajver SD; Frank TS
Am J Pathol; 1996 May; 148(5):1671-8. PubMed ID: 8623934
[TBL] [Abstract][Full Text] [Related]
20. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.
Broaddus RR; Lynch HT; Chen LM; Daniels MS; Conrad P; Munsell MF; White KG; Luthra R; Lu KH
Cancer; 2006 Jan; 106(1):87-94. PubMed ID: 16323174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]